XML 35 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash Flows from Operating Activities    
Net loss $ (8,508,592) $ (4,491,868)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 41,850 2,877
Amortization of debt issuance costs 13,848 28,229
Amortization of bond premium 137,897   
Re-measurement of fair value of stock warrants liability 7,263 122,202
Stock based compensation 722,358 377,388
(Decrease) increase in cash arising from changes in assets and liabilities:    
Related party receivable (18,446) (10,813)
Prepaid expenses and other current assets 418,275 (742,029)
Restricted cash (100,000) 24,672
Deposits (10,478)   
Accounts payable 28,561 (112,943)
Accrued expenses and other payables (56,888) 28,071
Accrued interest (25,364) 8,387
Net Cash Used in Operating Activities (7,349,716) (4,765,827)
Cash Flows from Investing Activities    
Proceeds from maturities of short term investments 13,827,773   
Purchases of short term investments (8,783,623)   
Purchase of property and equipment (452,444) (5,194)
Net Cash Provided by (Used in) Investing Activities 4,591,706 (5,194)
Cash Flows from Financing Activities    
Proceeds from initial public offering, net of underwriters discounts    25,110,000
Proceeds from long term debt 1,435,283   
Payments on notes payable    (725,000)
Payments on convertible notes payable    (197,099)
Issuance of common stock    47,957
Proceeds from the exercise of stock options 37,719 540
Stock issuance costs    (942,052)
Net Cash Provided by Financing Activities 1,473,002 28,344,436
Net (Decrease) Increase in Cash and Cash Equivalents (1,285,008) 23,573,415
Cash and Cash Equivalents - Beginning of Period 4,566,992 5,030
Cash and Cash Equivalents - End of Period 3,281,984 23,578,445
Supplemental Disclosure for Cash Flow Information    
Interest paid 8,138 51,575
Supplemental Schedule of Noncash Investing and Financing Activities    
Beneficial conversion charge    2,300,000
Conversion of convertible note payable to accounts payable    197,099
Preferred stock dividend    361,668
Non-cash conversion of preferred stock into common stock    386
Cashless exercise of stock warrants 452,874   
Series B-1 Preferred Stock [Member]
   
Cash Flows from Financing Activities    
Issuance of preferred stock    $ 5,050,090